Dentsply Sirona Inc (XRAY) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
Total Revenue Chart for Dentsply Sirona Inc
Dentsply Sirona Inc (XRAY) revenue for FY2025 was USD 3.7B, a -3.0% change from FY2024. Dentsply Sirona Inc's revenue grew from USD 10.3M in 1985 to USD 3.7B in 2025 (35628.2% over 40 years). Earnings per share grew from USD 0.64 in 2000 to USD -4.41 in 2022 (-785.7%). Revenue compound annual growth rate: 5-year CAGR of 2.0%, 10-year CAGR of 3.2%, 20-year CAGR of 3.9%.
Total Revenue (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $1.70B
- Implied Share Price
- $8.52
- Enterprise Value
- $4.02B
- Revenue (TTM)
- $3.64B
- EBITDA
- $526.00M
- Profit Margin
- -14.99%
- Trailing P/E
- —
- Forward P/E
- 6.33
- Price/Book (MRQ)
- 1.44
- Price/Sales (TTM)
- 0.47
- EV/EBITDA
- 43.25
- EV/Revenue
- 1.10
- Dividend Yield
- 3.74%
- Book Value
- $6.58
- Free Cash Flow (FY2025)
- $104.00M
- Free Cash Flow Yield
- 6.12%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.